Fundraising FoxFind your path to Bruce
Sign up to see every warm intro you have to Bruce
- Paths you didn't know you had: your email and LinkedIn already hold routes to Bruce. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Dr. Bruce Taylor is Co-Founder of PredxBio and holds appointments at the University of Pittsburgh School of Medicine, where he serves as Distinguished Professor, Allegheny Foundation Professor of Computational and Systems Biology, and Senior Member of the Organ Pathobiology and Therapeutics Institute. His work applies quantitative systems pharmacology and patient digital twins to drug discovery in liver-related conditions, including metabolic dysfunction-associated steatotic liver disease, Type 2 Diabetes, and breast and melanoma metastases in the liver, using human microphysiology systems and computational systems pathology. He has worked in academia at Harvard, Carnegie Mellon University, and the University of Pittsburgh, and has founded or led biotechnology companies including Cellomics, Cellumen, Cernostics, PredxBio, and Biosystics.
VP Software Engineering at Predxbio
Intro paths
In turn, Bruce can intro founders to Predxbio's investors below.
Predxbio's investors · 6
Co-founders at Predxbio
Co-founder, Scientific & Business Advisor at Predxbio
Intro paths
In turn, Bruce can intro founders to Predxbio's investors below.
Predxbio's investors · 6
Co-founders at Predxbio
Frequently asked questions
- Who is Bruce?
- Dr. Bruce Taylor is Co-Founder of PredxBio and holds appointments at the University of Pittsburgh School of Medicine, where he serves as Distinguished Professor, Allegheny Foundation Professor of Computational and Systems Biology, and Senior Member of the Organ Pathobiology and Therapeutics Institute. His work applies quantitative systems pharmacology and patient digital twins to drug discovery in liver-related conditions, including metabolic dysfunction-associated steatotic liver disease, Type 2 Diabetes, and breast and melanoma metastases in the liver, using human microphysiology systems and computational systems pathology. He has worked in academia at Harvard, Carnegie Mellon University, and the University of Pittsburgh, and has founded or led biotechnology companies including Cellomics, Cellumen, Cernostics, PredxBio, and Biosystics.
- Where does Bruce work?
- Bruce is Co-founder, Scientific & Business Advisor of Predxbio.
- What companies did Bruce found?
- Bruce founded Predxbio.
Founder mafias
Carnegie Mellon University mafia562
Also came through, then founded or led a company.
University at Albany mafia32
Also came through, then founded or led a company.
About this profile. Compiled from public sources — Predxbio's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights